Publicacións nas que colabora con Marisa Crespo Leiro (36)

2024

  1. Reduced mitochondrial pyruvate carrier expression in hearts with heart failure and reduced ejection fraction patients: ischemic vs. non-ischemic origin

    Frontiers in Cardiovascular Medicine, Vol. 11

2023

  1. Risks of Ventricular Arrhythmia and Heart Failure in Carriers of RBM20 Variants

    Circulation: Genomic and Precision Medicine, Vol. 16, Núm. 5, pp. 434-441

  2. SERCA2a Protein Levels Are Unaltered in Human Heart Failure

    Circulation, Vol. 148, Núm. 7, pp. 613-616

  3. Soluble HLA-G levels in heart transplant recipients: Dynamics and correlation with clinical outcomes

    Transplant Immunology, Vol. 76

  4. Survival impact of previous statin therapy in patients hospitalized with COVID-19

    Medicina Clinica, Vol. 160, Núm. 1, pp. 1-9

2022

  1. Cardiac protection induced by urocortin-2 enables the regulation of apoptosis and fibrosis after ischemia and reperfusion involving miR-29a modulation

    Molecular Therapy - Nucleic Acids, Vol. 27, pp. 838-853

  2. Specialized Proresolving Mediators Protect Against Experimental Autoimmune Myocarditis by Modulating Ca2+ Handling and NRF2 Activation

    JACC: Basic to Translational Science, Vol. 7, Núm. 6, pp. 544-560

2021

  1. Clinical utility of genetic testing in patients with dilated cardiomyopathy

    Medicina Clinica, Vol. 156, Núm. 10, pp. 485-495

  2. Extracellular Matrix in Heart Failure: Role of ADAMTS5 in Proteoglycan Remodeling

    Circulation, Vol. 144, Núm. 25, pp. 2021-2034

  3. Risk predictors in a Spanish cohort with cardiac laminopathies. The REDLAMINA registry

    Revista Espanola de Cardiologia, Vol. 74, Núm. 3, pp. 216-224

2020

  1. Circulating miR-181a-5p as a new biomarker for acute cellular rejection in heart transplantation

    Journal of Heart and Lung Transplantation, Vol. 39, Núm. 10, pp. 1100-1108

  2. Mitochondrial pyruvate carrier abundance mediates pathological cardiac hypertrophy

    Nature Metabolism, Vol. 2, Núm. 11, pp. 1223-1231

  3. Prognostic implications of pathogenic truncating variants in the TTN gene

    International Journal of Cardiology, Vol. 316, pp. 180-183

2019

  1. AGT haplotype in ITGA4 gene is related to antibody-mediated rejection in heart transplant patients

    PLoS ONE, Vol. 14, Núm. 7

  2. Circulating Galectin-3 Following Heart Transplant: Long-term Dynamics and Prognostic Value

    Revista Espanola de Cardiologia, Vol. 72, Núm. 11, pp. 899-906

2018

  1. Comparison of the PI3K-AKT-mTOR Pathway Expression Profile in Tumoral Versus Nontumoral Tissue Samples From Heart Transplant Recipients

    Revista Espanola de Cardiologia, Vol. 71, Núm. 8, pp. 674-676

  2. Donor polymorphisms in genes related to B-cell biology associated with antibody-mediated rejection after heart transplantation

    Circulation Journal, Vol. 82, Núm. 5, pp. 1351-1359

  3. Polymorphisms in genes related to the complement system and antibody-mediated cardiac allograft rejection

    Journal of Heart and Lung Transplantation, Vol. 37, Núm. 4, pp. 477-485

2017

  1. Role of NOD1 in Heart Failure Progression via Regulation of Ca2+ Handling

    Journal of the American College of Cardiology, Vol. 69, Núm. 4, pp. 423-433

2016

  1. Analysis of mitochondrial proteins in the surviving myocardium after ischemia identifies mitochondrial pyruvate carrier expression as possible mediator of tissue viability

    Molecular and Cellular Proteomics, Vol. 15, Núm. 1, pp. 246-255